FibroGen Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About FibroGen Inc.
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
/ 
Frequently asked questions
To buy FibroGen Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for FibroGen Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for FibroGen Inc. is FGEN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
FibroGen Inc. has its primary listing on NASDAQ. You can trade FibroGen Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, FibroGen Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include FibroGen Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like FibroGen Inc..